STAMFORD, Conn., May 13 /PRNewswire/ -- Zargis Medical Corp., a
majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today
announced that it has been selected by the U.S. Army's Telemedicine
& Advanced Technology Research Center (TATRC) to present the
Company's latest technologies at the TATRC exhibit during this
year's American Telemedicine Association Conference (ATA), which
takes place May 16-18 at the Henry B.
Gonzalez Convention Center in San
Antonio, TX.
"We are honored to have been selected by TATRC to present our
industry leading medical devices at this premier conference,"
stated Zargis CEO, John Kallassy.
"This presentation represents the first major marketing event for
Zargis' new, award winning tele-auscultation platforms."
In addition to participating with TATRC at this conference,
Zargis will also be demonstrating its newly introduced
ZargisTelemed™ platform, which allows recordings from electronic
stethoscopes to be easily transmitted between healthcare
professionals via the Internet.
For more information about Zargis' tele-auscultation tools or to
arrange a demonstration call 609-488-4608.
About TATRC
TATRC is an office of the headquarters of the U.S. Army Medical
Research and Materiel Command (USAMRMC). TATRC fosters research on
health informatics, telemedicine/m-Health, medical training
systems, and computational biology, and promotes and manages
science and engineering in other key portfolios. Through an
extensive network of partners, TATRC is focused at both ends of the
research spectrum, exploring models of high risk and innovative
research, and putting research findings into the hands of
warfighters while looking toward wider civilian utility. TATRC
augments core medical research programs through special funding and
partnership opportunities.
About Zargis Medical Corp.
Zargis is a global medical device company focused on improving
health outcomes and cost-effectiveness through diagnostic support
software and innovation. Zargis is majority-owned by Speedus Corp.
(Nasdaq: SPDE), and both 3M Company and Siemens Corporate Research,
a division of Siemens AG (NYSE: SI), hold equity positions.
For additional information about Zargis or Speedus Corp.,
contact Peter Hodge at 888.773.3669
(ext. 23) or phodge@zargis.com, or visit the following Web sites:
www.zargis.com and www.speedus.com.
Statements contained herein that are not historical facts,
including but not limited to statements about the Company's
product, corporate identity and focus, may be forward-looking
statements that are subject to a variety of risks and
uncertainties. There are a number of important factors that could
cause actual results to differ materially from those expressed in
any forward-looking statements made by the Company, including, but
not limited to, the continuing development of the Company's sales,
marketing and support efforts.
SOURCE Speedus Corp.
